A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
Mayo Clinic
Mayo Clinic
Vanderbilt-Ingram Cancer Center
University of Colorado, Denver
The University of Texas Health Science Center, Houston
Technische Universität Dresden
Ohio State University Comprehensive Cancer Center
University Health Network, Toronto